Holen Sie sich die Stockscreener-App
113.76
1.74%
1.95
Handel nachbörslich:
113.76
Schlusskurs vom Vortag:
$111.81
Offen:
$110.77
24-Stunden-Volumen:
833.23K
Relative Volume:
1.40
Marktkapitalisierung:
$7.56B
Einnahmen:
$136.86M
Nettoeinkommen (Verlust:
$-168.69M
KGV:
-40.48
EPS:
-2.81
Netto-Cashflow:
$-113.49M
1W Leistung:
+2.98%
1M Leistung:
+12.64%
6M Leistung:
+74.51%
1J Leistung:
+138.34%
1-Tages-Spanne:
$108.56
$114.39
1-Wochen-Bereich:
$108.56
$116.00
52-Wochen-Spanne:
$45.91
$116.00
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
Firmenname
Rhythm Pharmaceuticals Inc
Sektor
Branche
Telefon
857-264-4280
Adresse
222 BERKELEY STREET, BOSTON, MA
Vergleichen Sie RYTM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
113.76 | 7.43B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-07-07 | Eingeleitet | Leerink Partners | Outperform |
| 2025-04-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-03-05 | Fortgesetzt | Stifel | Buy |
| 2025-01-02 | Eingeleitet | Jefferies | Buy |
| 2024-12-20 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-21 | Eingeleitet | Guggenheim | Buy |
| 2024-09-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-17 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-05-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-19 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-01-18 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-08-08 | Hochstufung | Goldman | Neutral → Buy |
| 2022-08-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-06-17 | Bestätigt | Needham | Buy |
| 2022-03-02 | Fortgesetzt | Stifel | Buy |
| 2022-02-17 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | Fortgesetzt | Goldman | Neutral |
| 2021-08-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-08-04 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-01-08 | Eingeleitet | Goldman | Sell |
| 2019-07-12 | Hochstufung | Stifel | Hold → Buy |
| 2019-07-08 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-03-13 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-09-07 | Fortgesetzt | Morgan Stanley | Overweight |
| 2018-06-25 | Bestätigt | Needham | Buy |
| 2018-06-15 | Bestätigt | Needham | Buy |
| 2017-10-30 | Eingeleitet | BofA/Merrill | Buy |
| 2017-10-30 | Eingeleitet | Needham | Buy |
Alle ansehen
Rhythm Pharmaceuticals Inc Aktie (RYTM) Neueste Nachrichten
Published on: 2025-11-02 22:26:41 - newser.com
Can Rhythm Pharmaceuticals Inc. (1RV) stock hold up in economic slowdown2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
Is Rhythm Pharmaceuticals Inc. stock positioned for digital transformationGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Rhythm Pharmaceuticals Hits New 52-Week High of $116.00 - Markets Mojo
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Can machine learning forecast Rhythm Pharmaceuticals Inc. recoveryJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com
Visualizing Rhythm Pharmaceuticals Inc. stock with heatmaps2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com
How currency fluctuations impact Rhythm Pharmaceuticals Inc. stock2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
Will Rhythm Pharmaceuticals Inc. stock benefit from automation2025 Dividend Review & Community Driven Trade Alerts - newser.com
How resilient is Rhythm Pharmaceuticals Inc. stock in market downturns2025 Bull vs Bear & AI Powered Market Trend Analysis - newser.com
Is it time to cut losses on Rhythm Pharmaceuticals Inc.2025 Big Picture & Technical Entry and Exit Alerts - newser.com
Will Rhythm Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells $323,753.15 in Stock - MarketBeat
Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowMarket Trend Review & Accurate Trade Setup Notifications - newser.com
Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersMarket Performance Recap & Breakout Confirmation Alerts - newser.com
Is Rhythm Pharmaceuticals Inc. reversing from oversold territoryQuarterly Risk Review & Free Expert Verified Stock Movement Alerts - newser.com
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) Investors Are Less Pessimistic Than Expected - 富途牛牛
Rhythm Pharmaceuticals (NASDAQ:RYTM) Sets New 1-Year HighHere's What Happened - MarketBeat
Rhythm Pharmaceuticals (RYTM) to Release Earnings on Tuesday - MarketBeat
Rhythm Pharmaceuticals stock reaches all-time high at 114.04 USD By Investing.com - Investing.com Australia
Three Boston biotechs await FDA decisions on new drugs by year-end - The Business Journals
Published on: 2025-10-29 02:54:50 - newser.com
Rhythm Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Rhythm Pharmaceuticals stock reaches all-time high at 114.04 USD - Investing.com
Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
Why Rhythm Pharmaceuticals Inc. stock is in analyst buy zone2025 Price Targets & Smart Allocation Stock Reports - newser.com
Finanzdaten der Rhythm Pharmaceuticals Inc-Aktie (RYTM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):